SugenTech Inc
KOSDAQ:253840
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tauron Polska Energia SA
F:1T5
|
PL |
SugenTech Inc
Net Issuance of Common Stock
SugenTech Inc
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SugenTech Inc
KOSDAQ:253840
|
Net Issuance of Common Stock
₩1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Net Issuance of Common Stock
-₩894.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Net Issuance of Common Stock
-₩18.1B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Net Issuance of Common Stock
₩2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Net Issuance of Common Stock
₩89.5m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Net Issuance of Common Stock
₩22.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SugenTech Inc
Glance View
Sugentech, Inc. develops in-vitro diagnostic systems and products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2016-11-11. The firm is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The firm distributes its products within the domestic market and to overseas markets, including Indonesia.
See Also
What is SugenTech Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
1B
KRW
Based on the financial report for Dec 31, 2025, SugenTech Inc's Net Issuance of Common Stock amounts to 1B KRW.
What is SugenTech Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-17%
Over the last year, the Net Issuance of Common Stock growth was 5 722%. The average annual Net Issuance of Common Stock growth rates for SugenTech Inc have been 6% over the past three years , -17% over the past five years .
